Beryl Capital Management LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
-611,941
(-92.2%)
New positions
5
Sold out positions
27
Turnover %
1372.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| CLSK | 29,341 | NEW |
| UNH | 16,229 | NEW |
| BTDR | 3,427 | NEW |
| BGFV | 1,271 | 629.2% |
| ELME | 1,226 | NEW |
| HNRG | 348 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| BPMC | -136,797 | -100.0% |
| SKAA | -135,974 | -100.0% |
| SpringWorks Therapeutics, Inc. | -99,505 | -100.0% |
| DNB | -66,345 | -100.0% |
| Vigil Neuroscience, Inc. | -36,620 | -100.0% |
| AVDX | -28,721 | -100.0% |
| CTLP | -27,709 | -100.0% |
| INOZYME PHARMA INC | -25,286 | -100.0% |
| G | -23,426 | -100.0% |
| DKS | -13,632 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|